In brief, what’s happening at Penn—whether it’s across campus or around the world.
For 120 years, academic and government researchers have been documenting how African Americans and other minority patients routinely experience lower levels of access and worse outcomes throughout the U.S. health care system. Decade after decade, these reports have issued calls for change but disparities in care have persisted.
FULL STORY AT Leonard Davis Institute →
The Penn inductees are Zoltan Arany, Susan Domchek, Scott Halpern, David Margolis, Maria Oquendo, and Drew Weissman.
FULL STORY AT Penn Medicine News →
Using a PARP inhibitor as maintenance therapy could provide a less toxic option for patients. Treatment either shrunk tumors or stopped them from growing in 17 of 19 patients in an interim analysis from a trial at the Abramson Cancer Center.
FULL STORY AT Penn Medicine News →
Driscoll has been chair of Penn’s Department of Obstetrics and Gynecology since 2005. She is widely recognized as a transformative leader and one of the world's leading obstetrician-gynecologist geneticists, specializing in the care of women with genetic disorders. She is also the director of Penn’s Center for Research on Reproduction & Women’s Health and the March of Dimes Prematurity Research Center.
FULL STORY AT Penn Medicine News →
Breastfeeding is an accepted practice for millions of women worldwide and strongly endorsed by the World Health Organization. To provide appropriate counseling about human milk and breastfeeding, it is important to understand cultural beliefs and customs related to the practice.
FULL STORY AT Penn Nursing News →
Researchers at the Abramson Cancer Center found that an inhibitor drug that targets a specific mutation in relapsed or refractory acute myeloid leukemia helps patients live almost twice as long as those who receive chemotherapy.
FULL STORY AT Penn Medicine News →
A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumors to shrink in the majority of evaluable patients. The early findings provide hope that this strategy involving a CD40 antibody, a checkpoint inhibitor, and standard-of-care chemotherapy could be effective treatment.
FULL STORY AT Penn Medicine News →
A Penn Medicine study shows technology tied to patient records pushing doctors toward a new therapy was more effective than just peer education.
FULL STORY AT Penn Medicine News →
A Penn Medicine study shows technology tied to patient records pushing doctors toward a new therapy was more effective than just peer education.
FULL STORY AT Penn Medicine News →
Penn Nursing’s Sharon Y. Irving has been awarded a Distinguished Nutrition Support Nurse Service Award from the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).
FULL STORY AT Penn Nursing News →
